ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Heme Oxygenase 1-Targeted Hybrid Nanoparticle for Chemo- and Immuno-Combination Therapy in Acute Myelogenous Leukemia.

Seok-Beom Yong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.